Corporate Results Monitor
FNArena's All-Year Round Australian Corporate Results Monitor.
Currently monitoring September-January 2026.
Figures shown as at 21 November 2026
FNArena subscribers receive the most current information. Please login with your account details.
TOTAL STOCKS:
38
Beats
13
In Line
12
Misses
13
Previous Corporate Results Updates
| Company | Result | Upgrades | Downgrades | Buy/ Hold/Sell | Prev Target | New Target | Brokers | Commentary |
|---|---|---|---|---|---|---|---|---|
| AMC - Amcor | MISS | 0 | 0 | 3/3/0 | 69.98 | 68.85 | 6 | Amcor's September-quarter result broadly met expectation but guidance for the December 2026 transition period was downgraded by approximately -5%. UBS pointed out lower interest and tax costs offset weaker operating earnings, as EBIT missed consensus by -2%. Free cash outflow reached -US$820m, reflecting weaker earnings and a -US$1.1bn working capital outflow due to resin price volatility. Ord Minnett questions management's ability to reduce leverage to around 3x by the end of 2027. Macquarie considers the December quarter downgrade as temporary as management is implementing corrective measures and maintaining its double-digit earnings growth forecast for calendar 2027. Three Hold-equivalent ratings and three Buy-equivalent ratings. |
| ANZ - ANZ Bank | IN LINE | 0 | 3 | 0/4/2 | 36.07 | 36.34 | 6 | ANZ Bank's FY26 report proved marginally better than forecasts. Ord Minnett observed robust cost management, including $984m in savings while Suncorp synergies offset weaker revenue and lending margins. Macquarie sees limited upside scope fort further savings. Management commentary infers the bank's lower capital buffer and historically low bad debt charges leave ANZ exposed to deteriorating credit conditions. Flat guidance for FY27 costs and relatively stable 1H27 margins has UBS questioning the scope for further share price outperformance. Four Hold-equivalent ratings, including two downgrades from Buy. One downgrade to Lighten from Hold. |
| ALL - Aristocrat Leisure | IN LINE | 0 | 0 | 6/1/0 | 65.59 | 70.84 | 7 | Weakness in the Aristocrat Leisure share price was likely more about the CEO's retirement and the limited familiarity with incoming CEO Daphne Guisard. Citi notes EBITA slightly beat consensus, with Gaming and Product Madness outperforming, while Interactive disappointed. Macquarie forecasts 10%-15% annual EPS growth in the near term, supported by North American gaming momentum and expansion in online casino markets. Interactive earnings are also expected to benefit from market share gains, new market openings and improving margins Six positive ratings against Bell Potter on Hold. |
| BOQ - Bank of Queensland | IN LINE | 0 | 1 | 0/3/3 | 6.28 | 6.35 | 6 | Bank of Queensland's 2H FY26 net interest margin (NIM) of 1.73% exceeded the consensus expectation by around 3bps, supported by a shrinking loan book and reduced funding requirements. Overall, the result broadly fell in line with forecasts. Citi acknowledges management has executed well but now needs to transition back to volume growth from productivity gains against a more challenging macro backdrop. Macquarie sees renewed margin pressure as the bank returns to mortgage growth and competes more aggressively for deposits. It's also felt ongoing technology investment, cost inflation and intensifying competition will constrain returns. Morgans downgrades to make it three Sell ratings versus three on Neutral/Hold. |
| XYZ - Block | BEAT | 0 | 0 | 0/0/0 | 95.00 | 95.00 | 0 | Not only did Block manage to outperform expectations with its Q3 update, management also lifted FY26 gross profit guidance and provided preliminary FY27 guidance for at least 15% gross profit growth with a 31.5% adj. operating margin. Both Afterpay and Square are currently outperforming expectations. UBS (Buy) sees further upside from distribution investment, lending and AI products, with newer initiatives not required to achieve preliminary targets. Citi reiterates its Buy rating. |
| CSC - Capstone Copper | IN LINE | 1 | 0 | 4/0/0 | 16.83 | 16.58 | 5 | Capstone Copper's September quarter production fell short of forecasts following operational disruptions and adverse weather. Management expects 2026 production towards the lower end of 200–230kt guidance and cash costs towards the upper end of US$2.45–US$2.75/lb. Macquarie highlights adjusted EBITDA of US$358m was 7% above consensus and 17% ahead of its own forecast, supported by stronger copper prices and lower costs at Mantoverde. Citi points out Capstone delivered its eighth consecutive record quarterly adjusted EBITDA result of US$358m despite weaker-than-expected copper production. Morgans points out this is one of only two mid-cap ASX-listed pure copper exposures. Ord Minnett upgrades to Buy to make it four, with Macquarie on research restriction. |
| CAT - Catapult Sports | MISS | 0 | 0 | 4/0/0 | 5.16 | 4.74 | 4 | Catapult Group's 1H27 result was broadly in line with expectations. Disappointment came through higher capital expenditure on new Vector 8 and Perch P2 products, expected to constrain cash flow through FY28. Higher-than-expected acquisition costs, mainly tied to Impect, caused a wider statutory net loss of -US$19.1m. The share price fell -17% on the day. Morgans highlights solid operating metrics, with customer churn at 4.5%, a record Rule of 40 score of 38% and free cash flow up 13% to US$9.3m. UBS sees scope for a re-rating as the gap between underlying and statutory earnings narrows in FY28. Four Buy ratings. |
| CIA - Champion Iron | MISS | 0 | 0 | 1/1/0 | 3.63 | 2.65 | 2 | Champion Iron posted a much weaker than expected 2Q revenue and earnings result on softer realised prices, attributed to lower provisional pricing, and higher diesel/freight costs. The ramp up of the direct reduction pellet feed plant is on track for March 2027. UBS now forecasts a net operating loss in FY27 and downgrades FY28/FY29 EPS by -30% to -45% on weaker realisation/sticker costs. Bell Potter highlights rising net debt, elevated costs and temporary covenant relief extending to March 2027. Macquarie has ceased coverage. One Buy, one Speculative Hold. |
| CHI - Channel Infrastructure NZ | BEAT | 0 | 0 | 0/1/0 | 0.00 | 0.00 | 1 | Channel Infrastructure NZ delivered first half earnings that were ahead of Macquarie's forecast. FY26 guidance for EBITDA has increased to NZ$103m-NZ$108m. The broker assesses the result reinforces the quality of the infrastructure business and the company's ability to convert underutilised assets into contracted earnings. The main debate centres on timing. Storage projects are moving into cash flow while the Seadra FID is now likely in 2027. Funding uncertainty has increased. Neutral rating and NZ$3.38 target retained. |
| CVL - Civmec | BEAT | 0 | 0 | 1/0/0 | 2.30 | 2.30 | 1 | Civmec's Q1 net profit of $18.4m, up 75.2%, seems to have positively surprised. Bell Potter notes a significant uplift in activity across the construction division. Major multi-disciplinary projects were progressed and an order book of approximately $1.5bn was reported as of October. Bell Potter observes tendering activity remains robust and well distributed across sectors. EPS estimates are revised up 7% for FY27 and 8% for FY28. Buy rating maintained. Target rises to $2.30 from $2.20. Stockbroker Morgans doesn't seem keen to also update. |
| DVP - Develop Global | MISS | 0 | 0 | 1/0/0 | 6.50 | 5.80 | 1 | Develop Global's FY26 performance outperformed Bell Potter's expectations, with FY27 guidance signaling confidence in Woodlawn and the ramping up of Pioneer Dome. But the broker reduced EPS estimates for FY27 by -23% and FY28 by -27% to reflect downgraded mining services revenue, lower Pioneer Dome spodumene DSO recovery and modestly higher Woodlawn operating costs, as well as higher interest rates. Buy rating retained. Target is reduced to $5.80 from $6.50. |
| DNL - Dyno Nobel | MISS | 1 | 0 | 4/1/0 | 4.35 | 3.96 | 5 | Citi described Dyno Nobels FY26 earnings result as "messy" with both beats and misses across the divisions, As articulated by Morgan Stanley, DNA was 1% above consensus expectations, DNAP rose 10% and missed consensus by -1% and DNEL came in -40% down year-on-year, and -27% lower than consensus. Higher interest costs featured which impacted with cash conversion weak, and net debt more than anticipated. For Ord Minnett, EPS forecasts were downgraded on higher interest costs, while FY27 guidance also missed consensus by -5%. Morgans points to the planned maintenance and shutdowns as culprits for downgrading earnings forecasts. Four Buy-equivalent ratings including one upgrade to Accumulate from Hold. Two Hold ratings, pending an update from UBS. |
| EBR - EBR Systems | IN LINE | 0 | 0 | 2/0/0 | 0.70 | 0.73 | 2 | EBR Systems' Q3 performance proved broadly in line with expectations. Morgans notes 40 WiSE implants were completed, although September activity slowed sharply, prompting management to refocus its commercial strategy. A favourable US Medicare coverage decision is expected to improve patient access, although sustained adoption remains uncertain. Bell Potter highlights management believes sales disruptions experienced in August and September are largely behind the company, with a renewed focus on sales execution and manufacturing efficiencies. Both rate the stock a Speculative Buy. |
| ELD - Elders | BEAT | 0 | 1 | 1/4/0 | 6.84 | 7.18 | 5 | Elders' FY26 underlying EBIT beat forecasts, driven by lower corporate costs, resilient Rural Services and Wholesale divisions, and a solid contribution from Delta Agribusiness. Morgans expects further Delta synergies and systems benefits, although softer livestock prices and property markets present headwinds. Citi highlights favourable rainfall and higher livestock prices as potential FY27 earnings drivers. Bell Potter's expectations were higher and therefore its forecasts are cut but an improved balance sheet helps to offset the downgrades. El Nino features as an important unknown. Morgans downgrades to Hold to make it four against Macquarie on Outperform. |
| GNC - GrainCorp | BEAT | 1 | 1 | 2/1/0 | 7.30 | 7.68 | 3 | GrainCorp's FY26 EBITDA of $223m was in line with Macquarie and consensus forecasts, although underlying NPAT missed forecasts due to due to higher interest costs.The analyst highlighted improving grain export and crush margins, with management adopting its most positive outlook on margins in several years. FY27 and FY28 earnings forecasts are upgraded due to better margins and operating leverage. One upgrade to Buy-equivalent. Awaiting more updates. |
| IFT - Infratil | BEAT | 1 | 0 | 4/0/0 | 13.80 | 13.80 | 4 | Infratil's interim proportional EBITDA rising 30% y/y proved 9% ahead of consensus. FY27 operational EBITDA guidance was raised to NZ$1,370m–NZ$1,440m, supported by stronger contributions from CDC and One NZ. The company faces substantial investment requirements, with around -NZ$2bn in proportional capex expected in 2H27. Macquarie likes CDC's positive contracting outlook, with approximately 260MW of available capacity offering near-term opportunities. Citi sees the share price offering an attractive investment opportunity as macroeconomic pressures stabilise and structural growth drivers remain intact. UBS notes the stock is trading around a -27% discount to NAV, which is one of the greatest discounts in the last decade and compares to the -14% average. Morgans upgrades to Buy to make it four out of four. |
| JHX - James Hardie Industries | BEAT | 0 | 0 | 3/2/0 | 44.13 | 44.45 | 5 | James Hardie Industries continues to navigate the challenging macro environment well. Morgan Stanley highlights the stronger than expected 2Q27 results with earnings (EBITDA) beating consensus by 9%, boosted by improved margins. Analysts see managements FY27 guidance as overly conservative against the robust 1H27 performance. UBS notes the beat, which was at the upper end of guidance, was supported by Sidings & Trim margins which were 230bps above expectations, a favourable pricing/mix and market share gains. Morgans points to further earnings upside from market share gains, albeit unchanged 2H27 guidance infers tough trading conditions. Four Buy equivalents and two Hold ratings. Macquarie has yet to update. |
| KMD - KMD Brands | MISS | 0 | 0 | 1/0/0 | 0.00 | 0.00 | 1 | FY26 underlying earnings (EBITDA) for KMD Brands (July year-end) more than doubled to NZ$42m, supported by 11% Kathmandu sales growth, improved gross margins and NZ$8m of tariff refunds. Higher operating costs prompt UBS to cut its FY27–FY29 earnings forecasts by -20%–29%. The broker forecasts FY27 earnings of NZ$54m, near the top of the NZ$52m–NZ$55m guidance range but expects limited operating leverage. It is felt the balance sheet has been de-risked following the equity raising. The company has received several preliminary takeover approaches. UBS lowers its target to NZ$2.55 from NZ$3.50 and retains its Buy rating, mainly on valuation grounds. |
| 360 - Life360 | MISS | 0 | 0 | 2/0/0 | 30.36 | 29.45 | 2 | Life360 generated strong 3Q26 subscriber growth, with 5.3m new MAUs, which was ahead of Ord Minnett's forecast and up 18% y/y. For Bell Potter, the adj EBITDA was a 9% beat with a better margin of 19.9% against the 18.3% forecast. Paying circles rose by 188k versus the 179k expected. The disappointment is in advertising revenue which surged by 250%, but missed consensus by -8%. After a meeting with management, Citi is keen to stress the ongoing confidence in a recovery in advertising revenue growth in FY27, post a temporary setback. Management is targeting growth of 30% or more, which exceeds Citi's forecast of 25%. Six Buy ratings. |
| LNW - Light & Wonder | MISS | 0 | 0 | 7/0/0 | 186.86 | 183.29 | 7 | Light & Wonder's third-quarter adjusted earnings (EBITDA) rose 2% to US$383m, missing consensus forecasts by -1%, while FY26 earnings guidance is broadly in line, but weaker revenue performance across Gaming and SciPlay disappointed the market. UBS noted stronger margins and lower costs offset weaker revenue, while adjusted EPS rose 17% y/y, beating forecasts and consensus by 10%. Ord Minnett views land-based gaming as a standout, with around 1,085 machines installed during the quarter and North American shipment market share increasing to an estimated 25% from 21%. Seven Buy-equivalent ratings. |
| MQG - Macquarie Group | BEAT | 0 | 0 | 2/3/0 | 257.76 | 259.93 | 5 | Macquarie Group's first-half FY27 profit exceeded the consensus estimate by 9%, supported by stronger trading revenue, lower staff compensation costs and a favourable tax rate. Management upgraded FY27 guidance for Commodities and Global Markets but downgraded its outlook for Macquarie Capital, reflecting weaker advisory fees and delayed asset sales. The interim dividend rose to $3.25 from $2.80 y/y. Morgan Stanley sees upside earnings risk for FY27 and FY28 due to the pipeline of asset sales and generally good trading conditions for MAM and CGM. Citi sees more earnings risk given volatile market conditions and the uncertain timing of asset sale realisations. Two positive ratings versus three on Neutral/Hold. |
| MYR - Myer | IN LINE | 1 | 0 | 2/0/0 | 0.27 | 0.28 | 3 | Myer announced FY26 results which were in line with pre-guided financial metrics, though net profit slightly disappointed. The accompanying trading update was equally below forecasts, though September showed improvement. Morgan Stanley (Buy-equivalent) notes more promotional activity has not been enough to offset ongoing weakness from the consumer. Comparable sales in apparel fell by -5.9%, due to weakness in Portman's, while comparable sales for core retail rose 1.8%, due to one of the strongest Father's Day trading periods on record. Ord Minnett believes all the bad news has already been accounted for in the share price and upgrades to Buy from Hold. This broker also upgraded its FY27 EPS forecast by 23.7% on lower D&A and net interest expense forecasts. Citi (no rating) queries the possibility and scope of any recovery in broader industry sales given two more rate hikes from the RBA are likely. |
| NAB - National Australia Bank | MISS | 0 | 0 | 2/2/2 | 39.38 | 38.07 | 6 | National Australia Bank's second-half FY26 earnings fell -2%, missing consensus by around -5%, largely due to higher credit impairment charges. As highlighted by Morgan Stanley, the miss was largely due to higher-than-expected loan losses, due to deteriorating credit quality, with watch loans rising 15% in the September quarter amid signs of emerging customer stress. Underlying cost growth guidance of below 3% disappointed Ord Minnett, although core NIM improved 2bp to 1.83% in 2H26 and CET1 increased to 11.87% from 11.65%. Citi sees NAB's favourable exposure to business credit growth, forecast at 8% in FY27, along with an undemanding valuation relative to peers as positives. Two Buy ratings, two Hold rating and two Sell-equivalent ratings. |
| NHC - New Hope | IN LINE | 0 | 2 | 1/1/2 | 5.46 | 5.64 | 4 | New Hope's key metrics had been pre-released but FY26 statutory NPAT of $161m missed forecasts due to higher finance expenses. The underlying margin declined by -30% y/y to $45/t due to lower realised thermal coal prices. Record saleable coal production of 11.5mt and sales of 11.8mt both exceeded the top end of guidance. A fully franked final dividend of $0.30 was declared lifting the total for the year to $0.40, almost 18% above the prior year and well ahead of expectations. The business retains a substantial cash position of $525m, with management reaffirming a cash balance of around $300m is considered an appropriate minimum. Ord Minnett suggests the balance could be viewed as excess capital that may ultimately be returned to shareholders. The premium valuation received two downgrades to make it one Buy, one Hold and two Sell-equivalent ratings. |
| NEM - Newmont Corp | BEAT | 1 | 1 | 5/0/0 | 193.80 | 189.20 | 5 | Newmont Corp's September quarter performance proved slightly better than expected. Management reaffirmed 2026 production guidance. Unit cost guidance was lowered. Silver output is expected to fall around -30%. Total 2027 capex of approximately -US$3.85bn exceeds consensus, partly reflecting Red Chris spending. The December quarter is flagged to be the strongest for gold production in 2026. Morgans states, ultimately, a re-rating requires a turnaround in the gold price and the environment in the near term is not supportive, given the outlook for interest rates. Ord Minnett and Morgans upgrade to Accumulate. Three others have Buy ratings. |
| NWS - News Corp | BEAT | 0 | 0 | 3/0/0 | 55.92 | 55.92 | 3 | News Corp's 1Q27 EBITDA beat UBS and consensus forecasts by 6% and 3%, respectively, driven by stronger contributions from REA Group ((REA)) and Book Publishing. Dow Jones performed broadly in line, adding 197k net circulation subscribers, boosted by enterprise subscriptions, while Professional Information Business (PIB) revenue grew 5% y/y, below expectations. Free cash flow was weaker due to capex rising 26% y/y, and working capital timing, particularly higher Book Publishing inventories. Three Buy ratings. |
| NUF - Nufarm | IN LINE | 0 | 0 | 3/2/0 | 3.59 | 3.65 | 5 | Nufarm's 25% y/y increase in FY26 underlying EBITDA landed at the upper end of guidance and slightly ahead of consensus. Seed Technologies was the standout with EBITDA rising 520% y/y, while cost savings of $57m exceeded the $50m target. Gross margins improved 320bp to 30.8%, operating cash flow rose 45% and gearing declined to 2.0x from 2.7x. FY27 guidance implies EBITDA growth of around 8% to $410m, with further benefits from cost reductions expected in 2H27 and FY28. Alas, a higher expected tax rate of 40%–45% weighs on the earnings outlook. The share price weakened on consensus FY27 EPS downgrades on the higher tax rate and weaker 2H27 earnings. Three Buy ratings versus two on Neutral/Hold. |
| ORI - Orica | IN LINE | 0 | 0 | 4/0/0 | 26.29 | 26.88 | 4 | Orica's FY26 EBIT came in 2% better than consensus due to stronger performances from Digital and Specialty Chemicals, while Blasting was broadly in line. Macquarie noted FY26 underlying profit of $590m beat consensus by 3%., alongside stronger-than-expected cash flow and a robust balance sheet. Leverage of 1.46 times provides capacity for further acquisitions, while reduced restructuring costs should improve earnings quality. Citi expects the stock to outperform into the upcoming investor day, which is viewed as a potential catalyst. Two Buy-equivalent ratings, pending three additional broker updates. |
| PMV - Premier Investments | IN LINE | 0 | 0 | 4/1/0 | 15.54 | 15.34 | 5 | Premier Investments' FY26 result was in line with lowered EBIT guidance beforehand. Bell Potter describes the early FY27 trading update as encouraging. Citi notes Peter Alexander is proving resilient in a difficult retail environment, with further growth potential from new stores and expansion of existing locations. Smiggle remains the key concern, with Citi forecasting weak sales growth in FY27 while awaiting evidence the strategic reset can drive a recovery. Macquarie likes the strategy change for Smiggle and the Peter Alexander store rollout. Management's comments suggest acquisitions could be prioritised, which Morgan Stanley views positively following the loss of Peter Alexander's UK growth opportunity. Bell Potter highlights the $391m cash balance and capacity for acquisitions. Four Buys versus one Neutral/Hold. |
| REA - REA Group | BEAT | 0 | 1 | 3/4/0 | 186.43 | 197.04 | 7 | REA Group's first-quarter FY27 update exceeded expectations, supported by stronger controllable yield growth and deferred revenue benefits. UBS highlighted strong controllable Buy yield growth of 14% included a 3ppt one-off benefit from rural listings, implying underlying growth of around 11% y/y. October listings fell -13%, or -8% on a like-for-like basis, highlighting a deteriorating market. Bell Potter spots some moderation in Buy yield growth. Accelerating operating costs are expected over the balance of FY27. Despite near-term listing volatility, Morgans remains positive on the group's market position, cash generation and pricing power. Four Hold-equivalent rating and one downgrade to Accumulate from Buy. Two Buy ratings remain. |
| RMD - ResMed | IN LINE | 0 | 2 | 4/2/0 | 39.13 | 40.88 | 6 | ResMed's Q1 performance beat consensus but management left FY27 guidance unchanged, indicating momentum is anticipated to slow. This was interpreted as a major negative in the US where the strong share price rally was instantly nullified. Macquarie sees scope for earnings upside. Morgan Stanley highlights the gross margin rose 50bps y/y to 62.5%, benefiting from the delayed timing of supply chain investments. Morgans notes mask innovation remains the key driver of growth, with the AirTouch fabric portfolio supporting adherence and re-supply. The potential return of competitor Philips in the US market remains a risk, albeit no-one knows when or to what extent. Morgans and Ord Minnett both downgrade to Accumulate. Elsewhere, it's two Buys against two Neutral/Holds. |
| STX - Strike Energy | MISS | 0 | 0 | 2/0/0 | 0.13 | 0.16 | 2 | Strike Energy announced FY26 underlying net loss of -$23.3m, -4% below consensus due to higher third party purchases and D&A but the result was largely "inconsequential" as a deal was struck with Hancock. Macquarie states that deal is a real win and indicates market recognition of Strike's large gas resource, which is no longer a stranded asset. Outperform rating and 15c target are retained. |
| SM1 - Synlait Milk | BEAT | 1 | 0 | 1/0/1 | 0.39 | 0.39 | 2 | Synlait Milk reported FY26 earnings that were slightly ahead of recent guidance. The company is expected to return to profitability in FY27 with the sale of loss-making assets and the resolving of manufacturing issues. The balance sheet remains stretched amid higher working capital; dividends are considered unlikely before FY29. Macquarie considers the second half EBITDA has provided a base on which to build. A new Middle East customer has meant the mitigation of -18% less in a2 English label volumes over the next 12 months. Macquarie upgrades to Buy, while UBS sticks with Sell. |
| TNE - TechnologyOne | IN LINE | 0 | 2 | 1/4/0 | 32.19 | 36.42 | 5 | TechnologyOne delivered yet another set of robust growth metrics, but it was mostly as expected. FY26 PBT, up 20% y/y, and ARR, up 18%, came in at the top end of guidance. PBT margins expanded 218bp to 32.4%, while the final dividend of 32.5c exceeded expectations. AI-driven Plus adoption supported ARR growth, with 100 deals generating around $30m in additional product and module sales. Management reiterated its FY30 targets of over $1bn ARR and PBT margins exceeding 35%. There's now universal agreement among analysts that first part looks overly conservative. A sharp rally on the day of release triggered two downgrades to Hold to make it four against one remaining Buy. |
| TUA - Tuas | MISS | 0 | 0 | 2/0/0 | 7.48 | 3.65 | 2 | Tuas' FY26 result slightly disappointed Citi but marginally beat Morgan Stanley. Both have reduced forecasts reflecting lower mobile assumptions and increased cybersecurity investment. Citi sees potential upside from stronger-than-expected growth in the Enterprise and SME markets. Morgan Stanley sees scope for mobile growth to reaccelerate and considers a favourable Singapore licence decision a potential catalyst. |
| WJL - Webjet Group | MISS | 0 | 0 | 0/1/0 | 0.41 | 0.30 | 1 | Morgans (Hold) lowers its target for Webjet Group to $0.30 from $0.40 following a "weak" 1H27 result, with underlying earnings (EBITDA) falling -51% to $7m, below expectations. Revenue declined -12% and underlying net profit fell -86%, reflecting weaker trading, lost Virgin Australia ((VGN)) commissions and operational problems. Morgans expects any turnaround to take time, despite management targeting $10m in annualised cost savings by FY28. |
| WBC - Westpac | MISS | 0 | 0 | 1/1/4 | 33.96 | 33.60 | 6 | A decline in net interest margin in the second half of -3 basis points drove Westpac's slight miss to earnings expectations. Cost containment and bad debts both surprised positively. Morgans suggests achieving FY29 financial targets now requires significant outperformance against forecasts. Macquarie offers the challenging revenue backdrop still leaves downside risk to earnings and consensus forecasts. It's felt the bank's strategy remains on track, with management continuing to deliver on its Unite transformation program despite a more challenging revenue environment. Forecasts have been pared back. One Buy, one Hold and four Sell-equivalent ratings. |
| XRO - Xero | BEAT | 0 | 0 | 4/0/0 | 113.51 | 114.30 | 4 | Xero's 1H27 adj EBITDA, up 3% y/y came in -2% below consensus but US growth was stronger-than-expected, with revenue up 51% y/y, boosted by Melio growing by 57% y/y, 8% ahead of forecasts. Australian subscriber additions of 9k were the strongest since 1H24, with ARPU up 8%. Management now expects to achieve the Rule of 40 in FY27, 12 months ahead of schedule, with FY28 aspirations upgraded. Macquarie highlighted AI is viewed as additive rather than disruptive, with 1m customers using AI features and engineering productivity improving 2.5 times. The market cheered the up to $1bn opportunistic share buyback announcement. More updates to follow. |
Total: 38
ASX50 TOTAL STOCKS:
10
Beats
4
In Line
3
Misses
3
Total Rating Upgrades:
1
Total Rating Downgrades:
6
Total target price movement in aggregate:
0.07%
Average individual target price change:
0.68%
Beat/Miss Ratio:
1.33
ASX200 TOTAL STOCKS:
26
Beats
9
In Line
9
Misses
8
Total Rating Upgrades:
4
Total Rating Downgrades:
13
Total target price movement in aggregate:
-5.22%
Average individual target price change:
-0.67%
Beat/Miss Ratio:
1.13
Yet to Report
Indicates that the company is also found on your portfolio
Friday
20 November
Friday
27 November
Monday
30 November
Tuesday
1 December
Wednesday
2 December
Thursday
3 December
Friday
4 December
Wednesday
9 December
Thursday
10 December
Friday
11 December
Listed Companies on the Calendar
| Date | Code | |
| 26/11/2026 | AIH | FY26 earnings report |
| 23/11/2026 | ALQ | 1H27 earnings report |
| 24/11/2026 | ARX | H1 earnings report |
| 17/11/2026 | CAT | H1 earnings report |
| 08/12/2026 | CKF | H1 earnings report |
| Date | Code | |
| 16/11/2026 | ELD | FY26 earnings report |
| 26/11/2026 | FPH | 1H27 earnings report |
| 23/11/2026 | GTK | FY26 earnings report |
| 18/11/2026 | IFT | 1H27 earnings report |
| 07/12/2026 | MTS | 1H27 earnings report |
| Date | Code | |
| 19/11/2026 | NUF | FY26 earnings report |
| 17/11/2026 | TNE | FY26 earnings report |
| 25/11/2026 | WEB | H1 earnings report |
| 18/11/2026 | WJL | H1 earnings report |
